Location History:
- Cambridge, GB (2007)
- London, GB (2007 - 2013)
- Fulbourn, GB (2008 - 2014)
- Helions Bumpstead, GB (2014 - 2021)
- Essex, GB (2011 - 2023)
- Suffolk, GB (2015 - 2023)
Company Filing History:
28 out of 47 
7 out of 11 
4 out of 4 Years Active: 2007-2025
Areas of Expertise:
Title: Innovator Niall A. Armes: Pioneering Advances in Nucleic Acid Amplification Technologies
Introduction: Niall A. Armes, based in Fulbourn, GB, is a prominent inventor recognized for his substantial contributions to the field of nucleic acid amplification. With an impressive portfolio of 42 patents, he has advanced the capability and efficiency of DNA amplification assays, especially through recombinase polymerase amplification (RPA) methodologies.
Latest Patents: Among his latest inventions are two noteworthy patents that demonstrate his innovation and expertise in nucleic acid technologies. The first patent, titled "Recombinase Polymerase Amplification," introduces novel engineered recombinase enzymes and their utility in performing DNA amplification assays. This invention features various recombinase systems with distinct biochemical activities and optimized requirements for loading factors and single-stranded DNA binding proteins.
The second significant patent, "Automated Nested Recombinase Polymerase Amplification," describes a flu assay system that enhances automation in the RPA process. This invention comprises a sample module, a microfluidic nucleic acid amplification device, and an analyzer, facilitating the fully automated amplification of target polynucleotide sequences through a two-round amplification process.
Career Highlights: Niall has held key positions in companies known for their innovative approaches in diagnostics and life sciences. He has worked at Alere San Diego, Inc. and Abbott Diagnostics Scarborough, Inc., contributing significantly to their research and development efforts in molecular diagnostics and amplification techniques.
Collaborations: Throughout his career, Niall has collaborated with esteemed colleagues, including Olaf Piepenburg and Derek L. Stemple. These collaborations have played a vital role in advancing his research and the development of groundbreaking technologies in nucleic acid amplification.
Conclusion: Niall A. Armes exemplifies the spirit of innovation in the biosciences. His extensive patent portfolio underscores his dedication to developing advanced technologies that improve the accuracy and efficiency of nucleic acid amplification, making a lasting impact on diagnostics and research methodologies in the field.